Minoxidil and finasteride after a hair transplant: benefits, timing and precautions
Grafts do not need minoxidil or finasteride in order to take: once implanted, follicles from the donor area keep the low sensitivity to male pattern hair loss that they had at their original site. Both medicines are aimed at your native hair, the hair around the grafted area that keeps thinning for as long as the hair loss remains active. In a randomised trial of men undergoing a transplant, finasteride 1 mg taken before and after surgery improved the non-transplanted hair surrounding the grafts (Leavitt et al., 2005).
For a minoxidil lotion, the wait depends on how the scalp heals: recommendations agreed in 2026 through a Delphi process, by an international panel that included hair transplant surgeons, place its return to the grafted area between day 7 and day 14. The same statement allows low-dose oral minoxidil to restart one to three days after the operation, when it was already prescribed (Gupta et al., 2026). In the 2005 trial, finasteride was not interrupted around surgery. These timings are markers, and your surgeon adapts them to how your scalp has healed after your hair transplant in Turkey.
Starting either treatment is a medical decision. Finasteride is for men and is prescription-only; for hair loss in the UK it is available only on a private prescription, at your own cost, and not on the NHS (NHS, 2023). It is generally not recommended for women, which leaves minoxidil as the only one of the two that can be considered for them.
Why take a treatment if the grafts hold?
Male pattern hair loss combines a genetic predisposition with the action of dihydrotestosterone (DHT), a hormone made from testosterone that can stop hair growing (NHS, 2023). Follicles at the rear and sides of the head largely resist this effect, which is precisely why the surgeon harvests them: once implanted on top of the scalp, they keep that behaviour. Our article on how DHT affects hair follicles explains the hormonal mechanism in more depth.
The hair already present in the recipient area before surgery has no such protection. The trial by Leavitt and colleagues starts from this observation: the coverage gained through a transplant can be eroded if the pre-existing hairs keep shrinking and falling out (Leavitt et al., 2005). Over the years, a dense grafted zone may end up surrounded by sparse hair, and the stock of follicles available at the back of the head, which does not renew itself, then decides whether a second hair transplant remains possible.
Who stands to gain the most?
The expected benefit is clearer when hair loss is still progressing in a younger man, or when the grafts were placed among fine native hairs at risk of disappearing. The benefit shrinks when little native hair remains around the grafted zone. On an area that was already bald and fully grafted, finasteride cannot bring back hair that has gone: its role is limited to the follicles still active around it.
Conversely, when older photos show hair loss that has been stable for several years, the case for treatment weakens. Your age, the extent of the areas still covered and how well you tolerate medicines complete the assessment that the surgeon carries out while preparing your treatment plan. The hair transplant guide describes each stage of that preparation, followed by the procedure itself.
Finasteride: what the transplant trial measured
Finasteride is a 5-alpha reductase inhibitor: it stops testosterone turning into DHT, which slows hair loss, and the NHS says some improvement can be expected after three to six months (NHS, 2023). Our dedicated article on finasteride explains how it works, who it suits and who should avoid it.
Leavitt and colleagues followed 79 men with male pattern hair loss, between 20 and 45 years old, randomised under double-blind conditions: 40 received finasteride and 39 a placebo, starting four weeks before surgery and continuing to the 48th week afterwards (Leavitt et al., 2005). Two measures were used to judge the outcome: an expert dermatologist’s assessment of global scalp photographs, and hair counts on macrophotographs. At week 48, both were significantly better on finasteride. A visible gain in hair across the upper and frontal scalp was recorded in 67% of the men on placebo and in 94% of those taking finasteride.
The placebo group improves as well, since its grafts grow: the gap between the two groups therefore reflects what the medicine adds to surgery, on the hair surrounding the transplanted zone. The treatment was generally well tolerated during the study. These results come from a single 48-week trial in young men, and they concern the hair around the grafts rather than the survival of the grafts themselves.
Starting four weeks before the operation was the study protocol, not a rule for everyone. If you already take finasteride, mention it while you prepare: your surgeon and your prescriber will tell you whether it continues around the procedure. If you do not, nothing requires you to start it in a hurry before you travel: the NHS asks you to tell the doctor first if you have ever had depression or thoughts of harming yourself (NHS, 2023), and that conversation deserves time with your GP or a dermatologist.
Minoxidil: lotion, foam or tablet
Minoxidil works without acting on hormones. Originally a blood pressure medicine, it increases blood flow to the hair roots at low doses, so that hairs grow for longer and new hairs start growing sooner (Royal Berkshire NHS Foundation Trust, 2025). This complements finasteride, which acts upstream on DHT, and the two can be combined on medical advice. A separate article on minoxidil compares its formulations and how each one is used.
As a lotion or foam
Applied to the scalp as a solution or a foam, minoxidil is used for both male and female pattern hair loss, and the foam can be bought over the counter in the UK (Gloucestershire Hospitals NHS Foundation Trust, 2024; Royal Berkshire NHS Foundation Trust, 2025). It can take up to six months to work, and it only works for as long as you keep using it.
Because irritation where the product is applied is a known side effect (Gloucestershire Hospitals NHS Foundation Trust, 2024), the lotion waits until the incisions have closed and the scalp has settled. If a lotion has irritated your scalp before, mention it at your consultation: another formulation, such as a foam, can then be discussed with your prescriber.
As a low-dose tablet
Minoxidil tablets were first used in larger doses to treat high blood pressure; for hair loss they are prescribed at much lower doses (Royal Berkshire NHS Foundation Trust, 2025). Before a first prescription, the 2026 consensus asks for body weight and blood pressure to be measured; it expects a response within four to six months, accepts long-term use when the treatment works and is well tolerated, and rules minoxidil out for women who are pregnant or breastfeeding (Gupta et al., 2026). The Royal Berkshire leaflet adds that your GP should check your pulse and blood pressure regularly, and that the tablet is not advised if you already take medicine to lower your blood pressure.
Whether as a lotion or a tablet, minoxidil can increase shedding when you start it, a reaction that usually settles within the first six weeks as hairs are resynchronised into a growth cycle (Royal Berkshire NHS Foundation Trust, 2025). After a transplant, this can overlap with the post-operative shedding of grafts and nearby hairs, which our page on shock loss explains in detail. Both are temporary; let the team know if shedding spreads or goes on for longer.
What timeline should you follow around the procedure?
Before the transplant, give your patient coordinator the exact list of your hair loss treatments, with their form and dose. The surgeon then tells you whether the minoxidil lotion should be paused in the preceding days and whether finasteride continues. For your other medicines, such as blood thinners or supplements, a separate article sets out when to restart your other medicines.
During the first few days, nothing goes on the recipient area apart from the prescribed care. Washing, sleeping and protecting the scalp follow our aftercare instructions for the first weeks. A minoxidil tablet that was already prescribed can restart within the first few days, if the surgeon has no objection.
Between day 7 and day 14, the lotion can go back onto the grafted area, provided the scalp has healed, with no redness or pain. The remote follow-up lets you put the question to the team, with photos of the area, before the first application. Spread the product with your fingertips, without rubbing, and on the scalp only.
| Stage | Usual marker |
|---|---|
| Before you travel | Declare every treatment |
| Around the procedure | Finasteride: ask your doctors |
| Days 1 to 3 | Minoxidil tablet, if prescribed |
| Days 7 to 14 | Lotion on healed skin |
| Following weeks | Shedding possible, tell the team |
| Months 3 to 6 | First effects can be judged |
| Afterwards | Regular reviews with your doctor |
The effect of treatment shows on the areas that were not grafted, because the rebuilt hairline mainly reflects the surgeon’s work. Photos repeated at regular intervals, with the same light, framing and angles, make the comparison possible. First effects can be judged after three to six months of treatment (NHS, 2023; Gupta et al., 2026), after which your doctor regularly reviews whether it is worth continuing.
Side effects: what the NHS and the MHRA advise
Finasteride: sexual and psychiatric effects
The NHS lists problems getting an erection, less interest in sex and ejaculation problems among the common side effects of finasteride, affecting more than 1 in 100 people; they usually improve but can sometimes carry on after the medicine is stopped (NHS, 2023). Low mood is rarer, and anyone taking finasteride for hair loss who develops it should stop the medicine straight away and call their doctor or 111. The NHS also asks you to tell family or friends that you take it, so that they can help you notice a change in mood, and to dial 999 or go straight to A&E for any thoughts of self-harm.
The MHRA introduced patient alert cards for finasteride in 2024. In May 2026, after a further review of the evidence that took account of the outcome of a European regulatory assessment, it strengthened the product information, stating that sexual dysfunction may contribute to mood disorders: patients who experience depression or suicidal thoughts should stop treatment and seek medical advice, and any concern about sexual side effects should be discussed with a healthcare professional. Suspected side effects can be reported through the Yellow Card scheme (MHRA, 2026).
Three further precautions are worth knowing. Any lump, pain or swelling in the chest area, or discharge from a nipple, needs to be reported promptly, as these may be signs of a serious condition such as breast cancer. Finasteride affects the result of a PSA blood test, used to check for prostate cancer, so tell the doctor who arranges it that you take this medicine. Finally, the tablets are swallowed whole and should not be broken or crushed (NHS, 2023).
Minoxidil: skin, unwanted hair and heart-related signs
On the scalp, a lotion or foam can cause irritation and dandruff-like flakes, and unwanted hair can appear on the sideburns, forehead or arms when the product spreads beyond the scalp; one hospital leaflet advises stopping the treatment if side effects develop (Gloucestershire Hospitals NHS Foundation Trust, 2024). Headaches, dizziness and palpitations are rare with topical use, since very little of the medicine is absorbed.
With tablets, mainly at higher doses, the Royal Berkshire leaflet lists fluid retention with weight gain or ankle swelling, a faster heart rate and palpitations, chest pain or breathlessness, low blood pressure with dizziness or fainting, and extra facial and body hair (Royal Berkshire NHS Foundation Trust, 2025). Report these signs to your prescriber; chest pain or sudden breathlessness calls for 999 without delay.
How long should you take them, and what happens if you stop?
Both medicines only work while you take them. If you stop finasteride, the hair loss it was holding back will usually return (NHS, 2023); after stopping minoxidil, the hair returns to its pre-treatment state within three to four months (Gloucestershire Hospitals NHS Foundation Trust, 2024). Stopping does not affect the grafts, which remain as insensitive to DHT as they were at their donor site: what you lose is the native hair that the treatment was maintaining.
How long to continue is therefore decided with your doctor, and the answer can change over the years, since a transplant does not commit you to lifelong treatment. It takes into account how fast your hair loss is moving, how well you tolerate the treatment, your age and your plans, including a wish to have children: some men taking finasteride have reported poor sperm quality or infertility, and sperm usually returns to normal once the medicine is stopped (NHS, 2023). Choosing not to take a treatment remains a legitimate decision when hair loss is stable; the transplant plan takes this into account, particularly in where the hairline is placed and how the available grafts are distributed.
If finasteride does not suit you, minoxidil on its own remains possible, since it works differently. For women, finasteride is generally not recommended (NHS, 2023): minoxidil is then the only one of the two to consider, in a suitable formulation, provided the woman is neither pregnant nor breastfeeding (Gupta et al., 2026).
Planning your maintenance treatment with our team
From your first conversation, your English-speaking patient coordinator collects your photos along with a list of every hair loss treatment you take or have stopped. At our partner clinic, the surgeon assesses how much native hair is at risk and tells you whether a maintenance treatment makes sense in your case; this long-term view is built into the transplant plan so that your donor area is not exhausted. Prescribing and long-term monitoring then rest with your GP or a dermatologist at home, on a private prescription for finasteride.
When you are back home, you can send the team your questions throughout the 12-month post-operative follow-up, carried out remotely, for instance about shedding that goes on for longer; a side effect of the treatment itself should be reported first to the prescribing doctor. To plan your transplant in Istanbul, send us your photos; you will receive a free, no-obligation quote within 24 hours.
Sources
Gloucestershire Hospitals NHS Foundation Trust. (2024). Minoxidil [Patient information leaflet GHPI1535_04_24]. https://gloshospitals.nhs.uk/documents/20480/Minoxidil_GHPI1535_04_24.pdf
Gupta, A. K., Talukder, M., Williams, G., Abdelhamid, H., Akiska, Y. M., Alpeter, D., Boden, S. A., Erfan, R., Farjo, B., Farjo, N., Gabel, S., Harris, J. A., Hekimian, K. J., Keene, S., Krejci-Manwaring, J., Leonard, R. T., Nader, L. A., Pathomvanich, D., Perez-Meza, D., . . . Welter, R. J. (2026). Low-dose oral minoxidil (LDOM) and topical minoxidil: Consensus recommendations for managing male and female pattern hair loss in hair transplant patients using a modified Delphi process. Expert Opinion on Pharmacotherapy, 27(3), 253-261. https://doi.org/10.1080/14656566.2026.2642216
Leavitt, M., Perez-Meza, D., Rao, N. A., Barusco, M., Kaufman, K. D., & Ziering, C. (2005). Effects of finasteride (1 mg) on hair transplant. Dermatologic Surgery, 31(10), 1268-1276. https://doi.org/10.1111/j.1524-4725.2005.31202
Medicines and Healthcare products Regulatory Agency. (2026, May 11). MHRA strengthens safety warnings for finasteride and dutasteride. GOV.UK. https://www.gov.uk/government/news/mhra-strengthens-safety-warnings-for-finasteride-and-dutasteride
National Health Service. (2023, August 2). Finasteride. NHS. https://www.nhs.uk/medicines/finasteride/
Royal Berkshire NHS Foundation Trust. (2025). Minoxidil for hair loss [Patient information leaflet]. https://www.royalberkshire.nhs.uk/media/n3onzj1d/minoxidil-for-hair-loss_oct25.pdf